EXAS vs SDGR · rev $2.76B vs rev $255.9M
EXACT Sciences Corporation (EXAS) versus Schrodinger Inc (SDGR) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Schrodinger Inc (SDGR) is a health information services company listed on NASDAQ.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported SDGR revenue for 2025-12-31 was $255.9M. Net income was -$103.3M. Revenue was up 23.3% from 2024-12-31 to 2025-12-31. SDGR currently screens at market cap $1.16B.
EXAS currently screens at market cap $20.03B. SDGR currently screens at market cap $1.16B.
Not investment advice. Open the EXAS and SDGR stock pages for the full models.
Not investment advice.